Minimally Invasive Surgery in Pediatric Surgical Oncology

Hannah M Phelps1, Harold N Lovvorn2

  • 1School of Medicine, Vanderbilt University, Nashville, TN 37232, USA. hannah.m.phelps@vanderbilt.edu.

Insights

Minimally invasive surgery (MIS) for pediatric solid tumors may reduce complications and recovery time. This review examines MIS efficacy for oncologic resection in children and patient selection criteria.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Minimally invasive surgery (MIS) offers potential benefits like reduced morbidity, pain, and hospital stays for pediatric cancer patients.
  • Controversy exists regarding the oncologic safety and efficacy of MIS for achieving high-fidelity resections in childhood cancers.

Purpose of the Study:

  • To review the diverse applications of MIS in treating pediatric solid tumors, including definitive resection.
  • To summarize current evidence on the efficacy of MIS for oncologic resection in pediatric malignancies.
  • To outline patient selection criteria for MIS in pediatric cancer surgery.

Main Methods:

  • Literature review of studies on MIS for pediatric solid tumor resection.
  • Analysis of evidence supporting the oncologic outcomes of MIS.
  • Identification of criteria for selecting appropriate patients for MIS.

Main Results:

  • MIS demonstrates potential for reduced postoperative complications and faster recovery in pediatric cancer surgery.
  • Evidence supports the feasibility of achieving oncologic resection through MIS in select pediatric cases.
  • Specific patient and tumor characteristics can guide the selection for MIS.

Conclusions:

  • MIS is a viable approach for resecting pediatric solid tumors, offering significant advantages.
  • Careful patient selection is crucial for optimizing oncologic outcomes with MIS.
  • Further research may solidify MIS as a standard of care for specific pediatric malignancies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298
Types of Errors: Detection and Minimization01:12

Types of Errors: Detection and Minimization

Error is the deviation of the obtained result from the true, expected value or the estimated central value. Errors are expressed in absolute or relative terms.
Absolute error in a measurement is the numerical difference from the true or central value. Relative error is the ratio between absolute error and the true or central value, expressed as a percentage.
Errors can be classified by source, magnitude, and sign. There are three types of errors: systematic, random, and gross.
Systematic or...
11.4K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
412